In a recent study, Sayles et al used palbociclib treatment on patient‐derived osteosarcoma xenografts with CDK4 amplifications to show that CDK4/6 inhibition interferes with cell cycle progression, induces cell senescence with apoptosis, and decreases the pRb levels [21]. The gene discussed is CDK4; the disease is osteosarcoma.